Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000862255 | SCV001002734 | likely benign | Bardet-Biedl syndrome 3; Retinitis pigmentosa 55 | 2025-01-29 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002507470 | SCV002806396 | likely benign | Bardet-Biedl syndrome 1; Bardet-Biedl syndrome 3; Retinitis pigmentosa; Retinitis pigmentosa 55 | 2021-11-19 | criteria provided, single submitter | clinical testing | |
Clinical Genetics, |
RCV001701326 | SCV001918151 | benign | not specified | no assertion criteria provided | clinical testing | ||
Clinical Genetics DNA and cytogenetics Diagnostics Lab, |
RCV001727808 | SCV001971948 | likely benign | not provided | no assertion criteria provided | clinical testing | ||
Prevention |
RCV004745620 | SCV005351055 | likely benign | ARL6-related disorder | 2024-08-06 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |